Matthew Gregory's most recent trade in Sanuwave Health Inc was a trade of 1,574 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sanuwave Health Inc | Gregory Matthew Bazar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 1,574 | 1,574 | - | - | Stock Option (right to buy) | |
| Sanuwave Health Inc | Gregory Matthew Bazar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 41,333 | 41,333 | - | - | Stock Option (right to buy) | |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 144.00 per share. | 13 Sep 2022 | 514 | 4,752 (0%) | 0% | 144 | 74,016 | Common Stock |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.00 per share. | 13 Sep 2022 | 155 | 4,457 (0%) | 0% | 144 | 22,320 | Common Stock |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 144.00 per share. | 13 Sep 2022 | 140 | 4,612 (0%) | 0% | 144 | 20,160 | Common Stock |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 969 | 969 | - | - | Stock Option (Right to Buy) | |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 127.62 per share. | 14 Mar 2022 | 156 | 4,177 (0%) | 0% | 127.6 | 19,909 | Common Stock |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Sep 2021 | 4,938 | 4,938 | - | - | Stock Option (Right to Buy) | |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Grant, award, or other acquisition of securities at price $ 163.77 per share. | 21 Sep 2021 | 671 | 4,052 (0%) | 0% | 163.8 | 109,890 | Common Stock |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 162.18 per share. | 21 Sep 2021 | 33 | 4,021 (0%) | 0% | 162.2 | 5,352 | Common Stock |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 166.08 per share. | 17 Sep 2021 | 61 | 3,381 (0%) | 0% | 166.1 | 10,131 | Common Stock |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 166.09 per share. | 17 Sep 2021 | 53 | 3,442 (0%) | 0% | 166.1 | 8,803 | Common Stock |
| Clorox | Matthew Gregory | SVP - Chief Customer Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 169.68 per share. | 10 Sep 2021 | 63 | 3,481 (0%) | 0% | 169.7 | 10,690 | Common Stock |